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or fibrosis, Traykova-Brauch et al. adapted the Tet-on system 
for specific use in renal tubular cells. They used the promoter of 
the Pax8 gene as a candidate, because Pax8 is highly expressed 
in both fetal and adult kidney but is virtually absent from all 
other major organs except the thyroid gland. They inserted rtTA 
into the putative promoter of the Pax8 gene and identified two 
transgenic founders, one of which transmitted the transgene 
and was used for analysis. First, the authors showed functional 
expression of rtTA in vivo, by cross-breeding Pax8-rtTA mice 
with NZL-2 mice, a line with a tetracycline-responsive reporter 
encoding nuclear β-galactosidase. When double-transgenic 
(Pax8-rtTA/NZL-2) mice were given doxycycline, their kidneys 
developed strong β-galactosidase expression in all renal tubular 
cells. To generate a model of adult onset of PKD, they crossed 
Pax8-rtTA mice with TetO-MYC mice, which express c-MYC (a 
proto-oncogene that can cause renal cysts) under control of Ptet. 
Pax8-rtTA/TetO-MYC double-transgenic mice were healthy and 
had no detectable phenotype. However, upon receiving doxycy-
cline, these mice rapidly developed cysts in all renal tubules and 
renal failure. To generate a mouse model of transforming growth 
factor-β1 (TGF-β1) production in renal tubular epithelial cells, 
the authors then bred Pax8-rtTA mice with TetO–TGF-β1 mice. 
When these mice were treated with doxycycline, they developed 
a renal fibrosis phenotype, as shown by collagen I immunohis-
tochemistry (Figure). Finally, the researchers also developed a 
conditional knockout of the gene encoding tuberous sclerosis 
complex-1, which resulted in the early outgrowth of giant poly-
cystic kidneys reminiscent of autosomal recessive PKD. These 
studies show that the transgenic mouse line Pax8-rtTA allows 
kidney tubule-specific modulation of transgene expression in a 
highly efficient and tetracycline-dependent manner. Pax8-rtTA 
mice combine high activity with complete penetrance of the renal 
tubular compartment from early development throughout adult 
life. Pax8-rtTA mice can be used to derive both overexpression 
and kidney-specific knockout models. The inducibility of the 
transgene helps to avoid early lethality and further allows for 
the study of immediate early changes caused by ectopic gene 
expression. The reversibility of the transgene’s expression (in 
Tenofovir disoproxil fumarate 
versus adefovir dipivoxil  
for chronic hepatitis B
Tenofovir has been associated with clinical scenarios of acute renal 
failure and Fanconi’s syndrome. Although many questions remain 
regarding mechanism, risk factors, and frequency, the case reports 
and case series in a new study demonstrate a definite association 
and risk. Marcellin et al. conducted two double-blind phase 3 stud-
ies in which patients with chronic hepatitis B were randomized 
to receive tenofovir disoproxil fumarate or adefovir dipivoxil for 
48 weeks. Suppression of viral levels was greater among patients 
randomized to tenofovir than among those randomized to ade-
fovir (93% versus 63%, P<0.001, and 76% versus 13%, P<0.001, 
for hepatitis B e antigen (HBeAg)-negative and HBeAg-positive 
patients, respectively). Normalization of transaminases was also 
seen in a greater number of patients randomized to tenofovir. 
Patients with a creatinine clearance of less than 70 ml per minute 
were excluded from enrollment. Of the two end points reported (a 
confirmed serum creatinine increase of ≥0.5 mg/dl above baseline 
value and a confirmed creatinine clearance of <50 ml/min), only 
one subject in the adefovir arm experienced a confirmed serum 
creatinine increase of ≥0.5 mg/dl.
These results are similar to those of trials testing tenofovir among 
patients with HIV, wherein no renal safety issues were noted. Given 
that the same dose is used among persons with hepatitis B as among 
those with HIV, and that the therapy is not of a finite duration, 
similar events of kidney toxicity may be documented. Although 
tenofovir is significantly effective in the treatment of hepatitis B, 
its potential renal toxicities must be addressed. If events of acute 
renal failure are seen with this medication, report them to either 
the medication’s manufacturer or the Food and Drug Administra-
tion through the voluntary reporting system (http://www.fda.gov/
medwatch/how.htm). (N Engl J Med 2008; 359: 2442–2455)
Lynda Szczech
Modulation of renal diseases  
in transgenic mice
Conditional gene expression systems, such as the tetracycline-
dependent (Tet) system, provide an exceptional way of studying 
adult organ biology in gene-modified mice by controlling trans-
gene expression and by circumventing any developmental defect 
or embryonic or postnatal lethality. The Tet system consists of a 
tetracycline-dependent transactivator (tTA) and its associated 
promoter Ptet. The transactivator binds and activates Ptet, but its 
binding is directly controlled by tetracycline (or doxycycline). In 
the Tet-off system, tetracycline prevents binding of tTA to Ptet, 
whereas tetracycline is required for binding of the reverse tTA 
(rtTA) in the Tet-on system. To model clinically relevant renal 
diseases such as polycystic kidney disease (PKD), renal cancer, 
Renal fibrosis induced in Pax8-rtTA/TetO–TGF-β1 double-transgenic 
mice. Pax8-rtTA/TetO–TGF-β1 double-transgenic mice were treated with 
doxycycline, and overexpression of TGF-β1 led to massive extracellular matrix 
accumulation and prominent renal fibrosis, as indicated here by collagen I 
immunohistochemistry in non-induced (left) and induced (right) mice.
Tr
ay
ko
va
-B
ra
uc
h 
et
 a
l./
N
at
 M
ed
454   Kidney International (2009) 75 
journal  c lub
overexpression models) could even lead to models of renal 
disease reversal. (Nat Med 2008; 14: 979–984; doi:10.1038/
nm.1865)
Juan Oliver
Wnt7 signaling establishes  
the cortico-medullary axis  
of the mammalian kidney
The presence of a cortex and medulla is one of the most obvious 
anatomical features of the kidney. A recent paper from Andrew 
McMahon’s group sheds light on the mechanism by which this 
separation occurs. The authors found that a knockout of Wnt7b 
causes a loss of the medulla that appears as early as embryonic day 
15.5. This gene is expressed in the collecting tubules, pelvis, and 
ureter (Figure). Yet when Wnt7b was deleted, the collecting tubules 
were present and differentiated into principal cells and intercalated 
cells. As the medulla developed, evenly spaced thin branches of 
collecting tubules spread out of the pelvis into the kidney. In the 
mutant mice, these tubules were dilated and disorganized. Orienta-
tion of the mitotic spindle in a dividing cell of a tubule determined 
whether the tubule elongates or widens. The authors showed that 
most of the mitotic spindles changed their orientation from that 
favoring elongation to that producing widening. Surprisingly, even 
though Wnt7b is expressed only in the collecting tubules, the loop 
of Henle was also lost in these mutants, despite the fact that the loop 
differentiated into epithelia that express their characteristic markers 
(it did not lengthen because of lack of proliferation). Hence, Wnt7b 
produced by the collecting tubule acts on adjacent structures. In 
addition, interstitial cells in normal medulla and the collecting 
tubules express axin2, a target gene of the Wnt pathway. Confir-
mation of the role of canonical Wnt signaling in the development 
of the medulla was obtained when β-catenin removed from the 
interstitial cells of the medulla caused a similar phenotype to that 
produced in Wnt7b knockout mice. These studies show that Wnt7b 
produced by the collecting tubule and acting on the interstitial cells 
of the medulla lengthens the medullary tubular structures by organ-
izing the plane of cell division during mitosis. Whether Wnt7b has 
an autocrine action in addition to this paracrine role will need to 
be examined in further studies. (Development 2009; 136: 161–171; 
doi:10.1242/10.1242/dev.022087)
Qais Al-Awqati
Dietary non-human glycan 
mediates human susceptibility  
to a bacterial toxin
The AB5 toxins, secreted by a number of pathogenic bacteria, con-
tain five similar B subunits and a unique A subunit. The A subunit 
is the portion of the complex responsible for toxicity, as it corrupts 
essential cell functions. The B subunits form a five-membered ring, 
which allows binding to a receptor, likely a glycan, on the host 
cell surface. Receptor specificity is critical for the pathogenic pro-
cess, since it determines host susceptibility, tissue tropism, and the 
nature and spectrum of the resultant pathology. Subtilase cytotoxin 
(SubAB) is an AB5 toxin secreted by Shiga toxigenic Escherichia coli, 
which causes serious gastrointestinal disease in humans. SubAB also 
causes hemolytic uremic syndrome-like pathology in mice through 
SubA-mediated cleavage of BiP/GRP78, an essential endoplasmic 
reticulum chaperone.
To understand the receptor specificity of SubAB, Byres et al. per-
formed glycan array analysis. They found that the toxin had a high 
degree of binding specificity for glycans terminating with α2-3-linked 
residues of the non-human sialic acid Neu5Gc, a monosaccharide 
not synthesized in humans. They also confirmed SubAB specificity 
for Neu5Gc by using mouse tissues with a human-like deficiency 
of Neu5Gc and human cell lines fed with Neu5Gc. However, the 
authors discovered that Neu5Gc was present in the human colon—
on the epithelial surfaces and in the crypts, regions that also bound 
SubAB. However, binding of SubABA12 (with a mutation that abol-
ishes specific receptor interaction) was markedly diminished. Specific 
binding of SubAB to human kidney sections, particularly the glomer-
ular endothelium, was also observed, but not of SubABA12 (Figure). 
Human kidney vasculature also showed staining with an anti-Neu5Gc 
antibody. Thus, despite lack of Neu5Gc biosynthesis in humans, assim-
ilation of dietary Neu5Gc-containing products was shown to create 
high-affinity receptors on human gut epithelia and kidney vasculature. 
In addition, the lack of endogenously generated Neu5Gc-containing 
body fluid competitors in humans conferred susceptibility to the gas-
trointestinal and systemic toxicities of SubAB. Ironically, foods rich in 
Neu5Gc (red meats and bovine milk) are the most common source of 
Shiga toxigenic Escherichia coli contamination. Thus, these findings 
demonstrate that a bacterial toxin’s receptor is generated by metabolic 
incorporation of an exogenous factor derived from food. (Nature 2008; 
456: 648–652; doi:10.1038/nature07428)
Qais Al-Awqati
In situ hybridization analysis of Wnt7b expression in the mouse kidney.
Neu5Gc-dependent binding of SubAB to human tissues. Specific binding of 
SubAB to human kidney sections, particularly the glomerular endothelium, 
was observed, but this was not seen for SubABA12 mutant toxin.
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